Medizone technology stands out as being capable of satisfying both criteria. Due to ozone's demarcated therapeutic range, peripheral ozone concentrations need to be carefully calibrated and controlled. The amount of ozone drug delivered by the generator has to be appropriately integrated with the system that brings it to its target biological system. Medizone technology offers the capacity to satisfy this most important quality feature. All other delivery systems are unsound to the extent that they provide either too little or too much ozone, and show variable on-going performance, thus neglecting important pharmacodynamic demands.
Ozone is defined as a drug and therefore is subject to all applicable regulations.
This patent covers the use of ozone as applied to all biological systems, may they be a live patient, a member of the mammalian family, or biological materials destined for human or veterinary application. It has the capability to tell a clinician the exact dose of the drug being delivered. The thin film system is the only one offering reliable and consistent gaseous drug delivery, thus satisfying all the demands of rigorous laboratory and clinical requirements.